Search Results - "HENDRIKS, D. F"

Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen by Wang, W, Hendriks, D F, Scharpé, S S

“…A novel basic carboxypeptidase clearly different from carboxypeptidase N has been isolated from human plasma. It circulates as an enzymatically inactive…”
Get full text

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) by HENDRIKS, D. F., WILLEMSE, J. L.

Get full text

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? by WILLEMSE, J. L., HEYLEN, E., NESHEIM, M. E., HENDRIKS, D. F.

“…Procarboxypeptidase U (TAFI) is a recently discovered plasma procarboxypeptidase that upon activation by thrombin or thrombin‐thrombomodulin turns into a…”
Get full text

Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo‐ controlled, 12‐week study in early postmenopausal women by Post, M. S., Hendriks, D. F., Van Der Mooren, M. J., Van Baal, W. M., Leurs, J. R., Emeis, J. J., Kenemans, P., Stehouwer, C. D. A.

“… Post MS, Hendriks DF, van der Mooren MJ, van Baal WM, Leurs JR, Emeis JJ, Kenemans P, Stehouwer CDA (VU university medical center, Amsterdam, The…”
Get full text

Assay of Procarboxypeptidase U, a Novel Determinant of the Fibrinolytic Cascade, in Human Plasma by Schatteman, Katinka A, Goossens, Filip J, Scharpe, Simon S, Neels, Hugo M, Hendriks, Dirk F

“…Procarboxypeptidase U (proCPU) is a novel proenzyme found in human plasma. The active form, carboxypeptidase U (CPU; EC 3.4.17.20), retards the rate of…”
Get full text

The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome by BROUNS, R., HEYLEN, E., WILLEMSE, J. L., SHEORAJPANDAY, R., DE SURGELOOSE, D., VERKERK, R., DE DEYN, P. P., HENDRIKS, D. F.

“…See also Willemse JL, Brouns R, Heylen E, De Deyn PP, Hendriks DF. Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving…”
Get full text

Comparative study of commercially available procarboxypeptidase U (thrombin‐activatable fibrinolysis inhibitor) assays by HEYLEN, E., WILLEMSE, J. L., HENDRIKS, D. F.

Get full text

The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal by WILLEMSE, J. L., HEYLEN, E., HENDRIKS, D. F.

Get full text

Fast homogeneous assay for plasma procarboxypeptidase U by Schatteman, K A, Goossens, F J, Leurs, J, Kasahara, Y, Scharpé, S S, Hendriks, D F

“…Carboxypeptidase U (EC 3.4.17.20, CPU, TAFIa) is a novel determinant of the fibrinolytic rate. It circulates as an inactive zymogen, procarboxypeptidase U,…”
Get more information

Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy by WILLEMSE, J. L., BROUNS, R., HEYLEN, E., DE DEYN, P. P., HENDRIKS, D. F.

Get full text

Influence of the Thr325Ile polymorphism on procarboxypeptidase U (thrombin‐activable fibrinolysis inhibitor) activity‐based assays by WILLEMSE, J. L., MATUS, V., HEYLEN, E., MEZZANO, D., HENDRIKS, D. F.

Get full text

Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma by Willemse, J L, Leurs, J R, Hendriks, D F

Get full text

Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis by Schatteman, K A, Goossens, F J, Scharpé, S S, Hendriks, D F

“…Carboxypeptidase U (CPU, EC 3.4.17.20) is a recently described basic carboxypeptidase which circulates in plasma as the zymogen procarboxypeptidase U (proCPU)…”
Get more information

Immobilized carboxypeptidase N : a potent bioreactor and specific adsorbent for peptides by WEI WANG, HENDRIKS, D. F, SCHARPE, S. L

“…Carboxypeptidase N-Sepharose was prepared by covalent immobilization of purified human plasma carboxypeptidase N. More than 98% of the carboxypeptidase N was…”
Get full text

Proteolytic activation of purified human procarboxypeptidase U by Schatteman, Katinka A, Goossens, Filip J, Scharpé, Simon S, Hendriks, Dirk F

“…Carboxypeptidase U (CPU, EC 3.4.17.20) is a recently described basic carboxypeptidase which circulates in plasma as an enzymatically inactive precursor…”
Get full text

Exopeptidases in human platelets: an indication for proteolytic modulation of biologically active peptides by Scharpé, S L, Vanhoof, G C, De Meester, I A, Hendriks, D F, van Sande, M E, Muylle, L M, Yaron, A

“…The determination in human platelets of four exopeptidases--aminopeptidase P, dipeptidyl peptidase IV, carboxypeptidase N, and angiotensin converting…”
Get more information

Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study by Post, Marinka S, Leurs, Judith R, van der Mooren, Marius J, van Baal, W Marchien, Hendriks, Dirk F, Stehouwer, Coen D A, Kenemans, Peter

Get more information

3D hepatic spheroid models for the detection and study of compounds with cholestatic liability by Hendriks, D.F., Fredriksson Puigvert, L., Messner, S., Moritz, W., Ingelman Sundberg, M.

Get full text

LETTERS TO THE EDITOR: Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma by WILLEMSE, J. L., LEURS, J. R., HENDRIKS, D. F.

Get full text

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) by BERTINA, R. M., VAN TILBURG, N. H., HAVERKATE, F.

Get full text